ArticleCureus2025
Intravascular Lithotripsy for Suprarenal Coral Reef Aorta: A Novel Endovascular Approach to Complex Calcified Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coral reef aorta (CRA) is a rare atherosclerotic disease characterized by the presence of exophytic, calcified lesions protruding into the aortic lumen, causing severe stenosis of the aorta and its visceral and renal branches. Clinical presentation varies depending on the location and extent of the lesion. Treatment options include open surgery and endovascular approaches. Intravascular lithotripsy (IVL) is a novel endovascular technique that delivers acoustic shockwaves to modify calcified lesions, allowing luminal expansion. We report the case of a 76-year-old female with severe stenosis of the suprarenal aorta, right renal artery, superior and inferior mesenteric artery, and occluded left renal artery. Due to the anatomical complexity and lack of suitable landing zones, the suprarenal aorta was treated with IVL alone without stent or stent-graft placement. To preserve mesenteric perfusion, a balloon-expandable stent was deployed in the inferior mesenteric artery, which served as the dominant supply due to severe superior mesenteric artery stenosis. Following IVL, the patient reported immediate symptom resolution with no periprocedural complications. This case highlights the potential role of IVL as a safe, effective standalone treatment for complex CRA cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.